Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on May 30, 2002

Arteriosclerosis, Thrombosis, and Vascular Biology. 2002
Published online before print May 30, 2002, doi: 10.1161/01.ATV.0000023899.93940.7C
A more recent version of this article appeared on August 1, 2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
22/8/1354    most recent
01.ATV.0000023899.93940.7Cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Majors, A. K.
Right arrow Articles by Jacobsen, D. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Majors, A. K.
Right arrow Articles by Jacobsen, D. W.
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Risk Factors
Right arrow Fibrinogen/fibrin
Right arrow Other Vascular biology

Submitted on March 25, 2002
Accepted on May 10, 2002

Homocysteine Binds to Human Plasma Fibronectin and Inhibits Its Interaction With Fibrin

Alana K. Majors ; Shantanu Sengupta ; Belinda Willard ; Michael T. Kinter ; Reed E. Pyeritz ; and Donald W. Jacobsen *

From the Department of Cell Biology (A.K.M., S.S., B.W., M.T.K., D.W.J.), Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, and the Division of Medical Genetics (R.E.P.), Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia.

* To whom correspondence should be addressed. E-mail: jacobsd{at}ccf.org.

Objective—More than 70% of circulating homocysteine is disulfide-bonded to protein, but little is known about the specific proteins that bind homocysteine and their function as a consequence of homocysteine binding.

Methods and Results—When human plasma was incubated with [35S]L-homocysteine, most of the homocysteine bound to albumin. However, additional homocysteine-binding proteins were detected, and 1 of them comigrated with fibronectin. Treatment with 2-mercaptoethanol removed the bound homocysteine, demonstrating the involvement of disulfide bonding. In contrast, [35S]L-cysteine did not bind to fibronectin. Purified fibronectin bound {approx}5 homocysteine molecules per fibronectin dimer. SDS-PAGE of a limited trypsin digestion of homocysteinylated fibronectin showed that several tryptic fragments contained [35S]homocysteine. Sequence analysis demonstrated that the fragments containing bound homocysteine had localized mainly to the C-terminal region, within and adjacent to the fibrin-binding domain. Homocysteinylation of fibronectin significantly inhibited its capacity to bind fibrin by 62% (P<0.005). In contrast, neither the binding of fibronectin to gelatin nor its capacity to serve as an attachment factor for aortic smooth muscle cells was affected.

Conclusions—These results suggest that homocysteine may alter normal thrombosis and delay or interfere with wound healing by impairing the interaction of fibronectin with fibrin.


Key words: homocysteine • fibronectin • fibrin • atherosclerosis • thrombosis




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. M. Colgan and R. C. Austin
Homocysteinylation of Metallothionein Impairs Intracellular Redox Homeostasis: The Enemy Within!
Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 8 - 11.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. C. Barbato, O. Catanescu, K. Murray, P. M. DiBello, and D. W. Jacobsen
Targeting of Metallothionein by L-Homocysteine: A Novel Mechanism for Disruption of Zinc and Redox Homeostasis
Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 49 - 54.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Zinellu, E. Zinellu, S. Sotgia, M. Formato, G. M. Cherchi, L. Deiana, and C. Carru
Factors Affecting S-Homocysteinylation of LDL Apoprotein B
Clin. Chem., November 1, 2006; 52(11): 2054 - 2059.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Undas, J. Brozek, M. Jankowski, Z. Siudak, A. Szczeklik, and H. Jakubowski
Plasma Homocysteine Affects Fibrin Clot Permeability and Resistance to Lysis in Human Subjects
Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1397 - 1404.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Zinellu, S. Sotgia, L. Deiana, and C. Carru
Quantification of Thiol-Containing Amino Acids Linked by Disulfides to LDL
Clin. Chem., March 1, 2005; 51(3): 658 - 660.
[Full Text] [PDF]


Home page
J. Nutr.Home page
K. K. Kharbanda, D. D. Rogers II, M. E. Mailliard, G. L. Siford, A. J. Barak, H. C. Beckenhauer, M. F. Sorrell, and D. J. Tuma
A Comparison of the Effects of Betaine and S-Adenosylmethionine on Ethanol-Induced Changes in Methionine Metabolism and Steatosis in Rat Hepatocytes
J. Nutr., March 1, 2005; 135(3): 519 - 524.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. M. Scott, R. A.S. Ariens, and P. J. Grant
Genetic and Environmental Determinants of Fibrin Structure and Function: Relevance to Clinical Disease
Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1558 - 1566.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Lim, S. Sengupta, M. E. McComb, R. Theberge, W. G. Wilson, C. E. Costello, and D. W. Jacobsen
In Vitro and in Vivo Interactions of Homocysteine with Human Plasma Transthyretin
J. Biol. Chem., December 12, 2003; 278(50): 49707 - 49713.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Deussen
Adenosine--the missing link to understanding homocysteine pathogenicity or more smoke on the horizon?
Cardiovasc Res, August 1, 2003; 59(2): 259 - 261.
[Full Text] [PDF]